Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Neoadjuvant therapy is a well-established approach for the treatment of locally advanced or inflammatory breast cancer (BC) and has been increasingly used in recent years not only as a management strategy but also as a research tool. Recently, nanoparticle albumin-bound paclitaxel (nab-paclitaxel)/t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricciardi, Giuseppina Rosaria Rita, Franchina, Tindara, Russo, Alessandro, Schifano, Silvia, Ferraro, Giuseppa, Adamo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959577/
https://www.ncbi.nlm.nih.gov/pubmed/27499629
http://dx.doi.org/10.2147/OTT.S107930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959577/
https://www.ncbi.nlm.nih.gov/pubmed/27499629
http://dx.doi.org/10.2147/OTT.S107930

Ejemplares similares